JP collaborates with the Managing Directors on strategic financial matters including portfolio reviews, analyses and forecasts. He also analyzes financial industry trends, optimizes financing terms and mechanisms, and augments Versant’s management of working capital.
JP brings more than 8 years of industry experience at Genentech, where he was Senior Director and Head of Finance for the U.S. Bio-Oncology Business Unit. In this role, JP oversaw 13 brands, 32 indications and more than $12B in annual sales. JP earned an MBA from Harvard Business School with a concentration in Finance and Business Strategy.